Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumours × Leucovorin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 355 Rectal Neoplasms 183 Colonic Neoplasms 174 Pancreatic Neoplasms 111 Stomach Neoplasms 108 Neoplasm Metastasis 81 Neoplasms 54 Esophageal Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lymphoma 39 Adenocarcinoma Of Esophagus 35 Carcinoma, Hepatocellular 34 Leukemia 33 Burkitt Lymphoma 26 Adenocarcinoma 25 Cholangiocarcinoma 23 Biliary Tract Neoplasms 20 Gastrointestinal Neoplasms 19 Gallbladder Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Lymphoma, Non-Hodgkin 16 Esophageal Squamous Cell Carcinoma 13 Bile Duct Neoplasms 13 Osteosarcoma 12 Liver Neoplasms 12 Leukemia, Myeloid, Acute 12 Unspecified Adult Solid Tumor, Protocol Specific 11 Lymphoma, Large B-Cell, Diffuse 11 Breast Neoplasms 11 Leukemia, Biphenotypic, Acute 10

Interventions

adavosertib 4 Paclitaxel 3 pembrolizumab 2 olaparib 2 durvalumab 2 ceralasertib 2 Fluorouracil 2 Carboplatin 2 sintilimab 1 factor IX, factor VII, factor X, prothrombin drug combination 1 drug XX Z 1 danvatirsen 1 capivasertib 1 Rifampin 1 Pantoprazole 1 Omeprazole 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡